Acantholytic Pityriasis Rubra Pilaris Associated with Imiquimod 3.75% Application [PDF]
Case Reports in Dermatological Medicine, 2011 Imiquimod is an immunomodulator with both antitumor and antiviral properties. It is currently available in two cream formulations as Aldara (imiquimod 5%) and the newly approved Zyclara (imiquimod 3.75%).
Natasha Atanaskova Mesinkovska +3 more
doaj +2 more sources
Melanoma Arising after Imiquimod Use [PDF]
Case Reports in Medicine, 2014 Imiquimod belongs to the class of 1H-imidazo-[4,5-c]quinolones—drugs originally developed as nucleoside analogues with the aim of finding new potential antiviral agents (Harrison et al., 1988).
Sharad P. Paul
doaj +2 more sources
Erythema multiforme caused by topical imiquimod 3.75%
Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2023 Imiquimod, 3.75% cream, is a topical immunomodulator approved for treating actinic keratoses. Although local side effects are more frequent, it can also have systemic side effects. We report that imiquimod 3.75% can also produce erythema multiforme (EM),
César Magalhães +3 more
doaj +1 more source
Imiquimod-induced bullous pemphigoid: A case report
SAGE Open Medical Case Reports, 2023 A 72-year-old man treated with 3.5% imiquimod cream for scalp actinic keratoses developed the usual crusted and erosive reaction but developed bullae on the scalp, as well as the limbs and torso after several weeks into treatment.
Heidi Oi-Yee Li +2 more
doaj +2 more sources
Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment [PDF]
Acta Dermato-Venereologica, 2019 Lentigo maligna (LM) is treated to prevent progression to lentigo maligna melanoma (LMM). Surgery is the gold standard but an alternative treatment is off-label topical imiquimod.
Darryl C.K.S. Tio +4 more
doaj +3 more sources
Stevens-Johnson induced by imiquimod 5% cream: a case report [PDF]
Dermatology ReportsImiquimod 5% cream is an approved treatment for actinic keratoses, superficial basal cell carcinomas and anogenital warts. Severe systemic side effects associated to imiquimod 5% cream are rare, although few cases of erythema multiforme and Stevens ...
Ilaria Trave +5 more
doaj +2 more sources
Efficacy of 0.5% Tretinoin in the Treatment of Equine Aural Plaques. [PDF]
Vet DermatolBackground: Equine aural plaques are a benign form of auricular papillomatosis caused by equine papillomavirus. Despite the efficacy of 5% imiquimod cream, a marked local reaction is frequently observed during therapy, often requiring sedation before application.
de Mattos FS +14 more
europepmc +2 more sources
Imiquimod for Cervical and Vaginal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis. [PDF]
, 2023 OBJECTIVE To evaluate the treatment efficacy and the risk of adverse events of imiquimod for cervical intraepithelial neoplasia (CIN) and vaginal intraepithelial neoplasia (VAIN), compared with placebo or no intervention.
Hamanishi, Junzo +14 more
core +2 more sources
Long-Term Follow-Up of Lentigo Maligna Patients Treated with Imiquimod 5% Cream [PDF]
, 2023 Background: The study investigated the long-term efficacy of imiquimod 5% cream for LM, with a focus on disease recurrence and the possible prognostic factors of disease-free survival (DFS) in a cohort, with long-term follow-up.
S. Morteza Seyed Jafari +7 more
core +2 more sources
Skin TLR7 triggering promotes accumulation of respiratory dendritic cells and natural killer cells. [PDF]
, 2012 The TLR7 agonist imiquimod has been used successfully as adjuvant for skin treatment of virus-associated warts and basal cell carcinoma. The effects of skin TLR7 triggering on respiratory leukocyte populations are unknown.
Lohmeyer, Jürgen +29 more
core +2 more sources